Utilizing cell-free DNA to predict risk of developing brain metastases in patients with metastatic breast cancer

We compared cell-free DNA (cfDNA) results at MBC diagnosis in patients who developed brain metastases (BM) vs those without (non-BM) to understand genomic predictors of BM. Patients with cfDNA testing at MBC diagnosis (Guardant360®, 73 gene next generation sequencing) were identified. Clinical and g...

Descripción completa

Detalles Bibliográficos
Autores principales: Vidula, Neelima, Niemierko, Andrzej, Hesler, Katherine, Ryan, Lianne, Moy, Beverly, Isakoff, Steven, Ellisen, Leif, Juric, Dejan, Bardia, Aditya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10115848/
https://www.ncbi.nlm.nih.gov/pubmed/37076495
http://dx.doi.org/10.1038/s41523-023-00528-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10115848/
https://www.ncbi.nlm.nih.gov/pubmed/37076495
http://dx.doi.org/10.1038/s41523-023-00528-z

Ejemplares similares